M&A Transaction Database

Oncology M&A Transactions

Mergers and acquisitions in the Oncology subsector.

Never miss a transaction

Get instant notifications when new M&A transactions matching "Oncology" are published.

Filters

1 shown

Date:Aug 23, 2026
Ipsen Acquires Kartos Therapeutics for Oncology Drug

Ipsen finalizes Kartos Therapeutics acquisition, gaining navtemadlin, a Phase III myelofibrosis drug, strengthening its oncology portfolio.

Acquirer:Ipsen
Deal Value:n/a
Country:πŸ‡ΊπŸ‡Έ

Never Miss a Deal

Get weekly investment intelligence. Free forever.

You reached the end (1 deals).